These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

182 related articles for article (PubMed ID: 7917577)

  • 1. Marked decrease in trabecular bone quality after five years of sodium fluoride therapy--assessed by biomechanical testing of iliac crest bone biopsies in osteoporotic patients.
    Søgaard CH; Mosekilde L; Richards A; Mosekilde L
    Bone; 1994; 15(4):393-9. PubMed ID: 7917577
    [TBL] [Abstract][Full Text] [Related]  

  • 2. [Loss of trabecular bone strength and bone quality after 5 years of fluoride therapy for osteoporosis].
    Søgaard CH; Mosekilde L; Richards A; Mosekilde L
    Ugeskr Laeger; 1995 Apr; 157(14):2004-8. PubMed ID: 7740640
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Marrow space star volume in the iliac crest decreases in osteoporotic patients after continuous treatment with fluoride, calcium, and vitamin D2 for five years.
    Vesterby A; Gundersen HJ; Melsen F; Mosekilde L
    Bone; 1991; 12(1):33-7. PubMed ID: 2054234
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Effect of slow-release sodium fluoride on cancellous bone histology and connectivity in osteoporosis.
    Zerwekh JE; Hagler HK; Sakhaee K; Gottschalk F; Peterson RD; Pak CY
    Bone; 1994; 15(6):691-9. PubMed ID: 7873299
    [TBL] [Abstract][Full Text] [Related]  

  • 5. The effect of sodium fluoride on trabecular architecture.
    Aaron JE; de Vernejoul MC; Kanis JA
    Bone; 1991; 12(5):307-10. PubMed ID: 1782099
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Abnormal bone mineralization after fluoride treatment in osteoporosis: a small-angle x-ray-scattering study.
    Fratzl P; Roschger P; Eschberger J; Abendroth B; Klaushofer K
    J Bone Miner Res; 1994 Oct; 9(10):1541-9. PubMed ID: 7817799
    [TBL] [Abstract][Full Text] [Related]  

  • 7. [Histological effects of the treatment of osteoporosis with the combination of sodium fluoride, vitamin D and calcium].
    Briançon D; Charhon S; Edouard C; Meunier PJ
    Rev Rhum Mal Osteoartic; 1980 Dec; 47(12):693-8. PubMed ID: 7006045
    [TBL] [Abstract][Full Text] [Related]  

  • 8. The effect of prolonged fluoride therapy for osteoporosis: bone composition and histology.
    Lundy MW; Wergedal JE; Teubner E; Burnell J; Sherrard D; Baylink DJ
    Bone; 1989; 10(5):321-7. PubMed ID: 2605048
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Effects of fluoride on rat vertebral body biomechanical competence and bone mass.
    Søgaard CH; Mosekilde L; Schwartz W; Leidig G; Minne HW; Ziegler R
    Bone; 1995 Jan; 16(1):163-9. PubMed ID: 7742076
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Treatment of osteoporosis with human parathyroid peptide and observations on effect of sodium fluoride.
    Reeve J; Davies UM; Hesp R; McNally E; Katz D
    BMJ; 1990 Aug; 301(6747):314-8. PubMed ID: 2393738
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Effects of different regimens of sodium fluoride treatment for osteoporosis on the structure, remodeling and mineralization of bone.
    Balena R; Kleerekoper M; Foldes JA; Shih MS; Rao DS; Schober HC; Parfitt AM
    Osteoporos Int; 1998; 8(5):428-35. PubMed ID: 9850350
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Fluoride salts are no better at preventing new vertebral fractures than calcium-vitamin D in postmenopausal osteoporosis: the FAVOStudy.
    Meunier PJ; Sebert JL; Reginster JY; Briancon D; Appelboom T; Netter P; Loeb G; Rouillon A; Barry S; Evreux JC; Avouac B; Marchandise X
    Osteoporos Int; 1998; 8(1):4-12. PubMed ID: 9692071
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Lack of deleterious effect of slow-release sodium fluoride treatment on cortical bone histology and quality in osteoporotic patients.
    Zerwekh JE; Antich PP; Sakhaee K; Prior J; Gonzales J; Gottschalk F; Pak CY
    Bone Miner; 1992 Jul; 18(1):65-76. PubMed ID: 1422299
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Efficacy of long-term fluoride and calcium therapy in correcting the deficit of spinal bone density in osteoporosis.
    Farley SM; Libanati CR; Odvina CV; Smith L; Eliel L; Wakley GK; Kilcoyne R; Schulz EE; Baylink DJ
    J Clin Epidemiol; 1989; 42(11):1067-74. PubMed ID: 2809662
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Treatment of osteoporosis with sodium fluoride and calcium: effects on vertebral fracture incidence and bone histomorphometry.
    Lane JM; Healey JH; Schwartz E; Vigorita VJ; Schneider R; Einhorn TA; Suda M; Robbins WC
    Orthop Clin North Am; 1984 Oct; 15(4):729-45. PubMed ID: 6493736
    [TBL] [Abstract][Full Text] [Related]  

  • 16. High fluoride and low calcium levels in drinking water is associated with low bone mass, reduced bone quality and fragility fractures in sheep.
    Simon MJ; Beil FT; Rüther W; Busse B; Koehne T; Steiner M; Pogoda P; Ignatius A; Amling M; Oheim R
    Osteoporos Int; 2014 Jul; 25(7):1891-903. PubMed ID: 24777741
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Iliac bone biopsies at the time of periarticular stress fractures during fluoride therapy: comparison with pretreatment biopsies.
    Schnitzler CM; Mesquita JM; Gear KA; Robson HJ; Moodley GP; Smyth AE
    J Bone Miner Res; 1990 Feb; 5(2):141-52. PubMed ID: 2316402
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Stress fractures of the lower limbs in osteoporotic patients treated with fluoride.
    Orcel P; de Vernejoul MC; Prier A; Miravet L; Kuntz D; Kaplan G
    J Bone Miner Res; 1990 Mar; 5 Suppl 1():S191-4. PubMed ID: 2339628
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Influence of fluor salts, hormone replacement therapy and calcitonin on the concentration of insulin-like growth factor (IGF)-I, IGF-II and transforming growth factor-beta 1 in human iliac crest bone matrix from patients with primary osteoporosis.
    Pepene CE; Seck T; Diel I; Minne HW; Ziegler R; Pfeilschifter J
    Eur J Endocrinol; 2004 Jan; 150(1):81-91. PubMed ID: 14713283
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Histomorphometric evidence for increased bone turnover without change in cortical thickness or porosity after 2 years of cyclical hPTH(1-34) therapy in women with severe osteoporosis.
    Hodsman AB; Kisiel M; Adachi JD; Fraher LJ; Watson PH
    Bone; 2000 Aug; 27(2):311-8. PubMed ID: 10913928
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.